The results demonstrated that the ELISA potency assay is suitable for determining the potency of inactivated H5 A/Astrakhan/3212/2020 influenza vaccines. Moreover, the results demonstrate the importance of preparing libraries of antibody reagents for influenza subtypes with pandemic potential so that suitable mAbs are available for development of alternative mAb vaccine potency assays when needed.
Building similarity graph...
Analyzing shared references across papers
Loading...
Marcus Odin
Center for Biologics Evaluation and Research
Falko Schmeisser
Center for Biologics Evaluation and Research
Jackeline Soto
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and Research
Building similarity graph...
Analyzing shared references across papers
Loading...
Odin et al. (Sun,) studied this question.
synapsesocial.com/papers/69a13550ed1d949a99abf044 — DOI: https://doi.org/10.1111/irv.70206